Skip to main content
. 2018 May 23;361:k1786. doi: 10.1136/bmj.k1786

Table 3.

Association between atopic eczema and cardiovascular outcomes. Fitted to patients with complete data for all variables included in the models and from valid matched sets* (n=1  915  916, 1  842  759 unique patients)

Variables No Patient years at risk Events Hazard ratio (99% CI)†
Unadjusted Adjusted‡ Mediation model§
Primary outcomes
Myocardial infarction:
 Unexposed 1 528 477 9 361 522 17 178 1.00 (ref) 1.00 (ref) 1.00 (ref)
 Exposed 387 439 2 569 214 5561 1.10 (1.05 to 1.15) 1.06 (0.98 to 1.15) 1.04 (0.96 to 1.13)
Unstable angina:
 Unexposed 1 528 477 9 392 370 7059 1.00 (ref) 1.00 (ref) 1.00 (ref)
 Exposed 387 439 2 578 165 2460 1.22 (1.14 to 1.31) 1.25 (1.11 to 1.41) 1.17 (1.03 to 1.32)
Heart failure:
 Unexposed 1 528 477 9 375 383 16 983 1.00 (ref) 1.00 (ref) 1.00 (ref)
 Exposed 387 439 2 570 412 6441 1.21 (1.16 to 1.26) 1.19 (1.10 to 1.30) 1.17 (1.08 to 1.28)
Atrial fibrillation:
 Unexposed 1 528 477 9 316 331 28 571 1.00 (ref) 1.00 (ref) 1.00 (ref)
 Exposed 387 439 2 552 311 9892 1.12 (1.08 to 1.16) 1.11 (1.04 to 1.18) 1.07 (1.00 to 1.15)
Stroke:
 Unexposed 1 528 477 9 361 252 21 387 1.00 (ref) 1.00 (ref) 1.00 (ref)
 Exposed 387 439 2 568 749 7149 1.07 (1.03 to 1.12) 1.10 (1.02 to 1.19) 1.08 (1.00 to 1.16)
Cardiovascular death:
 Unexposed 1 528 477 9 427 420 30 116 1.00 (ref) 1.00 (ref) 1.00 (ref)
 Exposed 387 439 2 590 305 10 813 1.07 (1.03 to 1.11) 0.98 (0.92 to 1.06) 0.96 (0.89 to 1.03)
Secondary outcome
Coronary revascularisation:
 Unexposed 1 528 477 9 358 381 16 195 1.00 (ref) 1.00 (ref) 1.00 (ref)
 Exposed 387 439 2 567 932 5056 1.12 (1.07 to 1.17) 1.14 (1.05 to 1.24) 1.08 (0.99 to 1.17)
*

Matched sets including one exposed patient and at least one unexposed patient.

Estimated hazard ratios from Cox regression with current age as underlying timescale, stratified by matched set (matched on age at cohort entry, sex, general practice, and date at cohort entry).

Adjusted for current calendar period (1997-99, 2000-04, 2005-09, 2010-15), time since diagnosis (0-4, 5-9, 10-14, 15-19, ≥20 years), index of multiple deprivation at cohort entry, and time-varying asthma.

§

Adjusted additionally for body mass index and smoking at cohort entry, and time-varying hyperlipidaemia, hypertension, depression, anxiety, diabetes, and severe alcohol use.